Clinics in Dermatology
Volume 26, Issue 3 , Pages 283-287 , May 2008

Cutaneous manifestations of thyroid disease

References 

  1. Roberts CG, Ladenson PW. Hypothyroidism. Lancet. 2004;363:1558
  2. Shaha AR, Burnett C, Alfonso A, Jaffe BM. Goiters and airway problems. Am J Surg. 1989;158:378–380
  3. Leonhardt JM, Heymann WR. Thyroid disease and the skin. Dermatol Clin. 2002;20:473–481
  4. Leonhardt JM, Heymann WR. Cutaneous manifestations of other endocrine diseases. In: Fitzpatrick's dermatology in general medicine. 6th ed.. New York: Mc-Graw Hill; 2003;p. 1662–1670
  5. Heymann WR. Cutaneous manifestations of thyroid disease. J Am Acad Dermatol. 1992;26:885–902
  6. Zaias N. The nail in health and disease. In: 2nd ed.. Stamford: Appleton and Lange; 1990;p. 189–199
  7. Daniel CR. Nails in systemic disease. Dermatol Clin. 1985;3:431–443
  8. Miller J, Roling D, Spiers E, Davies A, Rawlings A, Leyden J. Palmoplantar keratoderma associated with hypothyroidism. Br J Dermatol. 1998;139:738–759
  9. Rich P. Nail changes due to diabetes and other endocrinopathies. Dermatol Ther. 2002;15:107–110
  10. Ai J, Leonhardt JM, Heymann WR. Autoimmune thyroid diseases: etiology, pathogenesis, and dermatologic manifestations. J Am Acad Dermatol. 2003;48:641–659
  11. Zettinig G, Weissel M, Flores J, Dudczak R, Vogelsang H. Dermatitis herpetiformis is associated with atrophic but not with goiterous variant of Hashimoto's thyroiditis. Eur J Clin Invest. 2000;30:53–57
  12. Alm J, Hagenfeldt L, Larsson A, et al. Incidence of congenital hypothyroidism: retrospective study of neonatal laboratory screening versus clinical symptoms as indicators leading to diagnosis. Br Med J (Clin Res Ed). 1984;289:1171
  13. Olivieri A, Stazi MA, Mastroiacovo P, et al. A population-based study on the frequency of additional congenital malformations in infants with congenital hypothyroidism: data from the Italian Registry for Congenital Hypothyroidism (1991-1998). J Clin Endocrinol Metab. 2002;87:557
  14. Castanet M, Park SM, Smith A, et al. A novel loss-of-function mutation in TTF-2 is associated with congenital hypothroidism, thyroid agenesis, and cleft palate. Hum Mol Genet. 2002;11:2051
  15. Hollowell JG, et al. Serum TSH, T4 and thyroid antibodies in the United States population (1998-1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489
  16. Tallstedt L, Lundell G, Torring O, et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med. 1992;326:1733
  17. Gorman CA, Garrity JA, Fatourechi V, et al. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology. 2001;108:1523
  18. Lyons CJ, Rootman J. Orbital decompression for disfiguring exophthalmos in thyroid orbitopathy. Ophthalmology. 1994;101:223
  19. Georgala S, et al. Pretibial myxedema as the initial manifestation of Graves' disease. J Eur Acad Dermatol Venereol. 2002;16:380–383
  20. Missner SC, Ramsay EW, Houck HE, Kaufmann CL. Graves' disease presenting as localized myxedema in a thigh donor graft site. J Am Acad Dermatol. 1998;29:846–849
  21. Fatourechi V, Pajouhi M, Fransway AF. Dermopathy of Graves' disease (pretibial myxedema). Review of 150 cases. Medicine. 1994;73:1–7
  22. Fatourechi V, Ahmed DD, Schwartz KM. Thyroid acropachy: report of 40 patients treated at a single institution in a 26 year period. J Clin Endocrinol Metab. 2002;87:5435–5441

PII: S0738-081X(07)00243-X

doi: 10.1016/j.clindermatol.2007.10.020

Clinics in Dermatology
Volume 26, Issue 3 , Pages 283-287 , May 2008